The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
Potential use of tight junction modulators to reversibly open membranous barriers and improve drug delivery
Open accessAbstract
The epithelial and endothelial barriers of the human body are major obstacles for drug delivery to the systemic circulation and to organs with unique environment and homeostasis, like the central nervous system. Several transport routes exist in these barriers, which potentially can be exploited for enhancing drug permeability. Beside the transcellular pathways via transporters, adsorptive and receptor-mediated transcytosis, the paracellular flux for cells and molecules is very limited. While lipophilic molecules can diffuse across the cellular plasma membranes, the junctional complexes restrict or completely block the free passage of hydrophilic molecules through the paracellular clefts. Absorption or permeability enhancers developed in the last 40 years for modifying intercellular junctions and paracellular permeability have unspecific mode of action and the effective and toxic doses are very close. Recent advances in barrier research led to the discovery of an increasing number of integral membrane, adaptor, regulator and signalling proteins in tight and adherens junctions. New tight junction modulators are under development, which can directly target tight or adherens junction proteins, the signalling pathways regulating junctional function, or tight junction associated lipid raft microdomains. Modulators acting directly on tight junctions include peptides derived from zonula occludens toxin, or Clostridium perfringens enterotoxin, peptides selected by phage display that bind to integral membrane tight junction proteins, and lipid modulators. They can reversibly increase paracellular transport and drug delivery with less toxicity than previous absorption enhancers, and have a potential to be used as pharmaceutical excipients to improve drug delivery across epithelial barriers and the blood-brain barrier.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–211 of 211
Clarke, H., Ginanni, N., Laughlin, K. V., Smith, J. B., Pettit, G. R., & Mullin, J. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.5035 · Cited by 23
Improvement of Intestinal Absorption of Macromolecules by Nitric Oxide Donor
Numata, N., Takahashi, K., Mizuno, N., Utoguchi, N., Watanabe, Y., Matsumoto, M., & Mayumi, T. (2000) · Journal of Pharmaceutical Sciences · doi:10.1002/1520-6017(200010)89:10<1296::aid-jps7>3.0.co;2-k · Cited by 23
The Effect of RMP-7 and its Derivative on Transporting Evens Blue Liposomes into the Brain
Zhang, X., Xie, Y., Jin, Y., Hou, X., Ye, L., & Lou, J. (2004) · Drug Delivery · doi:10.1080/10717540490494078 · Cited by 21
Fetih, G. N., Habib, F., Katsumi, H., Okada, N., Fujita, T., Attia, M., & Yamamoto, A. (2006) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.21.222 · Cited by 20
The Role of Histamine in Brain Oedema Formation
Joo, F., Kovács, J., Szerdahelyi, P., Temesvári, P., & Tósaki, Á. (1994) · Springer eBooks · doi:10.1007/978-3-7091-9334-1_19 · Cited by 18
Non-systemic delivery of topical brimonidine to the brain: A neuro-ocular tissue distribution study
Shunmugaperumal, T., Abdulrazik, M., & Benita, S. (2006) · Journal of drug targeting · doi:10.1080/10611860600992157 · Cited by 18
Zappulla, R. A., Spigelman, M., Omsberg, E., Rosen, J. J., Malis, L. I., & Holland, J. F. (1985) · Neurosurgery · doi:10.1227/00006123-198505000-00008 · Cited by 16
Doo, M.-H., Li, H., Jang, H.-I., Song, I., Chung, S., & Shim, C. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.06.014 · Cited by 13
Yu, Z., Li, S., Huang, Y.-Y., Fong, Y., & Wong, R. J. (2007) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7701062 · Cited by 13
Characterization of the influence of nitric oxide donors on intestinal absorption of macromolecules
Takahashi, K., Numata, N., Kinoshita, N., Utoguchi, N., Mayumi, T., & Mizuno, N. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.08.006 · Cited by 12
Zonula occludens toxin (Zot) interferes with the induction of nasal tolerance to gliadin
Rossi, M., Maurano, F., Luongo, D., et al. (2002) · Immunology Letters · doi:10.1016/s0165-2478(02)00038-x · Cited by 9
Cited by
Cancer nanomedicine: progress, challenges and opportunities
Shi, J., Kantoff, P. W., Wooster, R., & Farokhzad, O. C. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2016.108 · Cited by 5,873
Wearable sensors: modalities, challenges, and prospects
Heikenfeld, J., Jajack, A., Rogers, J., Gutruf, P., Tian, L., Pan, T., Li, R., Khine, M., Kim, J., Wang, J., et al. (2018) · Lab on a Chip · doi:10.1039/c7lc00914c · Cited by 1,434
Modern methods for delivery of drugs across the blood–brain barrier
Chen, Y., & Liu, L. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.11.010 · Cited by 1,006
Chitosan and Its Derivatives for Application in Mucoadhesive Drug Delivery Systems
M. Ways, T., Lau, W., & Khutoryanskiy, V. (2018) · Polymers · doi:10.3390/polym10030267 · Cited by 908
Evaluation of intranasal delivery route of drug administration for brain targeting
Erdő, F., Bors, L. A., Farkas, D., Bajza, Á., & Gizurarson, S. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.10.009 · Cited by 744
Metadata
- Authors
- Deli, M. A.
- Venue
- Biochimica et Biophysica Acta (BBA) - Biomembranes
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 1788
- Issue
- 4
- Pages
- 892-910
- ISSN
- 0005-2736 (ISSN-L)
- OpenAlex
- W2096996795
- Cited by
- 385
- References
- 211
- FWCI
- 8.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.